{"gene":"HSPB2","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1998,"finding":"HSPB2/MKBP physically associates with myotonic dystrophy protein kinase (DMPK), enhances its kinase activity in vitro, and protects it from heat-induced inactivation. HSPB2 exists as an oligomeric complex in muscle cytosol that is separate from the complex formed by alphaB-crystallin and HSP27.","method":"Co-immunoprecipitation, in vitro kinase activity assay, heat-inactivation protection assay, immunohistochemistry","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of kinase activation and heat protection, combined with co-IP binding and cellular localization; foundational study replicated in subsequent work","pmids":["9490724"],"is_preprint":false},{"year":2000,"finding":"HSPB2/MKBP and HSPB3 form a muscle-specific oligomeric complex (~150 kDa) that is completely independent of oligomers formed by HSP27, alphaB-crystallin, and p20. Interaction with DMPK was observed only for HSPB2 and not for the other sHSPs tested. HSPB2 did not associate with actin bundles in myotubes (unlike HSP27 and alphaB-crystallin). Expression of HSPB2 and HSPB3 is induced during muscle differentiation under control of MyoD.","method":"Native gel electrophoresis, co-immunoprecipitation, immunofluorescence, gel filtration chromatography, Western blot during differentiation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (native PAGE, Co-IP, immunofluorescence) in a single rigorous study; independently consistent with PMID 9490724","pmids":["10625651"],"is_preprint":false},{"year":2001,"finding":"HSPB2 localizes to mitochondria-associated cytoplasmic granules in differentiated muscle cells. Upon mild heat treatment, HSPB2 enriches in the mitochondrial fraction as shown by subcellular fractionation. Overexpression of HSPB2 protects cells from heat-induced cell death. Colocalization with mitochondria is independent of microtubules (not altered by colchicine).","method":"Immunofluorescence double-staining with mitochondrial markers, subcellular fractionation, colchicine treatment, cell viability assay","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by fractionation and co-staining with functional (cytoprotection) follow-up, single lab","pmids":["11697892"],"is_preprint":false},{"year":2003,"finding":"In ischemic heart and skeletal muscle, HSPB2 translocates from cytosol to the Z-/I-area of myofibrils. HSPB2 binds partially to actin-associated myofibrillar proteins (extractable by 1 M NaSCN, unlike alphaB-crystallin). This translocation is shared with other sHSPs under ischemic stress.","method":"Immunohistochemistry, subcellular fractionation with chaotropic extraction (NaSCN, urea), electron microscopy","journal":"Histochemistry and cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by fractionation and immunohistochemistry with functional context, single lab","pmids":["15480735"],"is_preprint":false},{"year":2003,"finding":"Hearts from alphaBC/HSPB2 double-knockout mice show a twofold reduction in contractile recovery after ischemia-reperfusion, increased necrosis and apoptosis, and 43% less reduced glutathione compared to wild-type, demonstrating that alphaBC and/or HSPB2 are required for myocardial protection from I/R injury.","method":"Knockout mouse model, isolated perfused heart I/R protocol, echocardiography, electron microscopy, glutathione assay, histology","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined cardiac phenotype and biochemical readout, but effects cannot be attributed exclusively to HSPB2 vs alphaBC since both genes are knocked out","pmids":["14592939"],"is_preprint":false},{"year":2005,"finding":"Isolated papillary muscles from alphaB-crystallin/HSPB2 double-knockout mice develop ischemic contracture earlier and to a higher degree during simulated ischemia, with attenuated recovery during reperfusion, indicating that alphaBC and/or HSPB2 maintain muscular elasticity during ischemia rather than supporting contraction itself (twitch force was not significantly altered).","method":"Isolated papillary muscle mechanical measurements, simulated ischemia-reperfusion, double-knockout mouse model","journal":"Pflugers Archiv : European journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct mechanical measurement in KO model with specific phenotypic readout, but dual KO precludes attribution solely to HSPB2","pmids":["16217658"],"is_preprint":false},{"year":2007,"finding":"Using mice with no HSPB2 (DKO crossed with CryAB transgenic), HSPB2 was found to specifically protect cardiac energetic balance: absence of HSPB2 caused impaired ATP and PCr recovery during reperfusion and massive energy wasting during inotropic stimulation, whereas CryAB protected mechanical/structural properties. These roles are non-redundant.","method":"31P NMR spectroscopy of isolated hearts, genetically modified mouse lines (DKO, CryAB transgenic, DKO/CryAB transgenic), ischemia/reperfusion and inotropic stress protocols","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — 31P NMR energetics in genetically stratified mouse lines cleanly dissecting HSPB2 from CryAB function with multiple orthogonal readouts","pmids":["17846079"],"is_preprint":false},{"year":2009,"finding":"Recombinant HSPB2 and HSPB3 form well-defined hetero-oligomers of 4, 8, 12, 16, 20, and 24 subunits in a strict 3:1 HSPB2:HSPB3 ratio. These complexes are thermally stable up to 40°C. The HSPB2/B3 complex exhibits poor chaperone-like activity (low surface hydrophobicity) and cannot interact with HSP20, HSP27, or alphaB-crystallin. Homomeric HSPB2 (not in complex with HSPB3) can associate with HSP20.","method":"Nanoelectrospray ionization mass spectrometry, sedimentation velocity analytical ultracentrifugation, circular dichroism spectroscopy, ANS fluorescence, co-immunoprecipitation","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted complex from recombinant proteins with multiple orthogonal biophysical methods in one rigorous study","pmids":["19715703"],"is_preprint":false},{"year":2010,"finding":"HspB2 inhibits apoptosis by suppressing activation of apical caspases-8 and -10 in the extrinsic apoptotic pathway, thereby blocking Bid cleavage and caspase-3 activation. Ectopic expression of HspB2 in breast cancer cells confers resistance to TRAIL- and TNF-α-induced apoptosis, and attenuates TRAIL anti-tumor activity in an orthotopic xenograft model.","method":"Ectopic overexpression in breast cancer cell lines, caspase activity assays, Bid cleavage immunoblot, caspase-3 activation assay, orthotopic xenograft mouse model","journal":"Breast cancer research and treatment","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional overexpression with defined molecular pathway readouts (caspase-8/10 and Bid cleavage) and in vivo validation, single lab","pmids":["20087649"],"is_preprint":false},{"year":2012,"finding":"HspB2 exhibits concentration-dependent oligomerization, subunit exchange between oligomers, and target protein-dependent chaperone activity in vitro: it prevents DTT-induced aggregation of insulin and heat-induced aggregation of alcohol dehydrogenase, partially prevents citrate synthase aggregation (co-precipitating with it), and suppresses amyloid fibril formation of α-synuclein.","method":"Sedimentation velocity, FRET subunit exchange assay, in vitro aggregation assays (insulin, ADH, citrate synthase), thioflavin T amyloid assay, far-UV CD, ANS fluorescence","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with multiple substrates and multiple orthogonal biophysical methods, single lab","pmids":["22272249"],"is_preprint":false},{"year":2012,"finding":"Cardiac-specific HSPB2 knockout mice show no difference in cardiac function or hypertrophic response at baseline or after pressure overload (transverse aortic constriction), but exhibit significantly reduced fatty acid-supported mitochondrial respiration and ATP production after TAC, indicating HSPB2 specifically supports mitochondrial metabolic function under cardiac stress.","method":"Cardiac-specific knockout mouse model, TAC surgery, echocardiography, mitochondrial respiration assay on permeabilized fibers, ATP production assay","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — cardiac-specific KO isolating HSPB2 function from CryAB, multiple functional readouts including direct mitochondrial assays","pmids":["22870288"],"is_preprint":false},{"year":2015,"finding":"Cardiac yeast two-hybrid screen and co-immunoprecipitation identified an HSPB2 cardiac interactome enriched in myofibril and mitochondrial proteins. GAPDH was validated as a client protein of HSPB2 through chaperone assays. The interactome partially overlaps with but is distinct from that of HspB5, supporting non-redundant functions.","method":"Yeast two-hybrid (cardiac library), co-immunoprecipitation, in vitro chaperone assay with GAPDH","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Y2H combined with co-IP validation and chaperone assay for GAPDH, single lab","pmids":["26465331"],"is_preprint":false},{"year":2017,"finding":"In mammalian cells, HSPB2 binds to BAG3 with weaker affinity than HSPB8. HSPB2 competes with HSPB8 for BAG3 binding. HSPB3 negatively regulates HSPB2 association with BAG3. In human myoblasts endogenously expressing HSPB2, HSPB3, HSPB8, and BAG3, BAG3 interacts selectively with HSPB8 rather than HSPB2.","method":"Co-immunoprecipitation in mammalian cells (overexpression), endogenous co-IP in human myoblasts","journal":"Cell stress & chaperones","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — reciprocal co-IP in both overexpression and endogenous settings, single lab, two conditions tested","pmids":["28181153"],"is_preprint":false},{"year":2018,"finding":"Crystal structure of human HspB2/B3 revealed a hetero-tetrameric assembly (3:1 HspB2:HspB3 ratio) where four α-crystallin domains form a flattened tetrahedron. Assembly is mediated by IXI/V motifs from terminal regions filling ACD pockets, and N-terminal region segments bind in unfolded conformation into anti-parallel shared ACD dimer grooves.","method":"X-ray crystallography of full-length human HspB2/B3 hetero-tetramer","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure of full-length human heteromer providing atomic-resolution assembly mechanism, consistent with prior biochemical data","pmids":["29969581"],"is_preprint":false},{"year":2023,"finding":"HSPB2 promotes neural regeneration and sensorimotor recovery after traumatic brain injury through autophagy. Mechanistically, HSPB2 may regulate autophagy by forming a complex with BAG3 and sequestosome-1/p62 to facilitate clearance of accumulated proteins in axons. Neuron-specific HSPB2 overexpression enhanced white matter integrity and CNS plasticity; autophagy inhibition (chloroquine) abrogated HSPB2's reparative function.","method":"Tamoxifen-induced neuron-specific transgenic overexpression mouse model, TBI model, autophagy flux assays, co-immunoprecipitation (HSPB2/BAG3/p62 complex), chloroquine inhibition, behavioral sensorimotor tests","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic overexpression with co-IP evidence for complex formation and pharmacological validation via autophagy inhibition, single lab","pmids":["37606039"],"is_preprint":false}],"current_model":"HSPB2 (MKBP) is a muscle-enriched small heat shock protein that forms a hetero-oligomeric complex with HSPB3 in a 3:1 ratio (crystal structure resolved), binds and activates myotonic dystrophy protein kinase (DMPK), exhibits target-dependent chaperone activity, localizes to mitochondria-associated compartments under stress, protects cardiac energetic balance (ATP/PCr) during ischemia-reperfusion and pressure overload by supporting mitochondrial function, inhibits extrinsic apoptosis by blocking caspase-8/10 activation, and promotes autophagy-dependent neural regeneration via a BAG3/p62 complex."},"narrative":{"mechanistic_narrative":"HSPB2 (MKBP) is a muscle-enriched small heat shock protein whose expression is induced during myogenic differentiation under MyoD control and that functions in cytoprotection, mitochondrial metabolic support, and protein quality control [PMID:10625651]. It assembles into a hetero-oligomeric complex with HSPB3 in a strict 3:1 stoichiometry; the resolved crystal structure shows four α-crystallin domains forming a flattened tetrahedron stabilized by IXI/V motifs filling ACD pockets and N-terminal segments threading into shared ACD dimer grooves [PMID:19715703, PMID:29969581]. This complex is distinct and independent from the oligomers formed by HSP27, αB-crystallin, and HSP20, underscoring a non-redundant role for HSPB2 in muscle [PMID:10625651, PMID:19715703]. HSPB2 binds and selectively activates myotonic dystrophy protein kinase (DMPK), enhancing its activity and protecting it from heat inactivation [PMID:9490724]. Beyond DMPK, HSPB2 displays target-dependent chaperone activity, suppressing aggregation of diverse substrates including insulin, alcohol dehydrogenase, citrate synthase, α-synuclein amyloid, and the validated cardiac client GAPDH [PMID:22272249, PMID:26465331]. In muscle it localizes to mitochondria-associated granules and translocates to myofibrillar Z-/I-bands or the mitochondrial fraction under heat or ischemic stress [PMID:11697892, PMID:15480735]. Cardiac-specific and double-knockout mouse studies establish that HSPB2 specifically preserves cardiac energetic balance—supporting ATP/phosphocreatine recovery and fatty-acid-supported mitochondrial respiration during ischemia-reperfusion and pressure overload—a function non-redundant with αB-crystallin's protection of mechanical/structural properties [PMID:17846079, PMID:22870288]. HSPB2 also inhibits extrinsic apoptosis by suppressing caspase-8/10 activation and downstream Bid cleavage [PMID:20087649], and promotes autophagy-dependent neural regeneration after traumatic brain injury via a complex with BAG3 and p62/sequestosome-1 [PMID:37606039]. Its interactions with BAG3 are weaker than those of HSPB8 and are negatively regulated by HSPB3 [PMID:28181153].","teleology":[{"year":1998,"claim":"Established the founding molecular function of HSPB2 by showing it is a kinase-binding chaperone that physically associates with and activates DMPK, distinguishing it from other muscle sHSPs.","evidence":"Co-immunoprecipitation, in vitro kinase activation, and heat-inactivation protection assays in muscle","pmids":["9490724"],"confidence":"High","gaps":["Structural basis of DMPK binding not defined","Physiological consequence of DMPK activation in vivo not tested"]},{"year":2000,"claim":"Defined HSPB2's partner specificity by showing it forms a dedicated muscle-specific HSPB2/HSPB3 oligomer independent of other sHSPs, induced during MyoD-driven differentiation.","evidence":"Native PAGE, co-IP, gel filtration, and immunofluorescence in differentiating muscle cells","pmids":["10625651"],"confidence":"High","gaps":["Stoichiometry not yet quantified","Functional consequence of HSPB3 partnership unresolved"]},{"year":2001,"claim":"Linked HSPB2 to organelle protection by demonstrating mitochondria-associated localization and stress-induced mitochondrial enrichment with cytoprotective effect.","evidence":"Immunofluorescence co-staining, subcellular fractionation, colchicine treatment, and viability assays in muscle cells","pmids":["11697892"],"confidence":"Medium","gaps":["Mitochondrial recruitment mechanism unknown","Single lab; molecular target at mitochondria not identified"]},{"year":2003,"claim":"Showed stress-dependent relocalization of HSPB2 to myofibrillar Z-/I-bands during ischemia, indicating a context-specific cytoskeletal protective role.","evidence":"Immunohistochemistry, chaotropic extraction fractionation, and electron microscopy in ischemic muscle","pmids":["15480735"],"confidence":"Medium","gaps":["Specific myofibrillar binding partners not identified","Translocation shared with other sHSPs, limiting specificity"]},{"year":2003,"claim":"Provided genetic evidence that αBC and/or HSPB2 are required for myocardial protection from ischemia-reperfusion injury.","evidence":"αBC/HSPB2 double-knockout mouse hearts in isolated perfused I/R protocol with glutathione and histology readouts","pmids":["14592939"],"confidence":"Medium","gaps":["Dual KO cannot attribute effect to HSPB2 alone","Mechanism connecting HSPB2 to glutathione status unclear"]},{"year":2005,"claim":"Refined the cardiac phenotype to maintenance of muscular elasticity during ischemia rather than active contraction.","evidence":"Isolated papillary muscle mechanics under simulated I/R in double-knockout mice","pmids":["16217658"],"confidence":"Medium","gaps":["Dual KO precludes HSPB2-specific attribution","Molecular basis of elasticity maintenance not defined"]},{"year":2007,"claim":"Genetically dissected HSPB2 from αB-crystallin, assigning HSPB2 a specific, non-redundant role in preserving cardiac energetic balance.","evidence":"31P NMR energetics in genetically stratified mouse lines (DKO, CryAB transgenic) under I/R and inotropic stress","pmids":["17846079"],"confidence":"High","gaps":["Molecular link between HSPB2 and ATP/PCr metabolism not pinpointed","Mitochondrial client mediating energetics not yet identified"]},{"year":2009,"claim":"Established the precise assembly and biophysical properties of the HSPB2/B3 complex, including its strict 3:1 stoichiometry and poor general chaperone activity.","evidence":"Native mass spectrometry, analytical ultracentrifugation, CD, ANS fluorescence, and co-IP on recombinant proteins","pmids":["19715703"],"confidence":"High","gaps":["Atomic structure not yet resolved","Reconciliation of poor chaperone activity with cytoprotective role unaddressed"]},{"year":2010,"claim":"Identified an anti-apoptotic function of HSPB2 acting on the extrinsic pathway by suppressing apical caspase-8/10 activation.","evidence":"Ectopic overexpression in breast cancer cells with caspase and Bid cleavage assays and orthotopic xenograft model","pmids":["20087649"],"confidence":"Medium","gaps":["Direct molecular target in the caspase cascade not identified","Overexpression context; endogenous relevance in muscle untested"]},{"year":2012,"claim":"Demonstrated that monomeric/homomeric HSPB2 has target-dependent chaperone activity against multiple aggregation-prone substrates, distinguishing its solo behavior from the inert HSPB2/B3 complex.","evidence":"Sedimentation velocity, FRET subunit exchange, and in vitro aggregation/amyloid assays with insulin, ADH, citrate synthase, and α-synuclein","pmids":["22272249"],"confidence":"High","gaps":["Physiological substrates in vivo not established","Determinants of target selectivity unknown"]},{"year":2012,"claim":"Used cardiac-specific knockout to isolate HSPB2 function, showing it specifically supports mitochondrial respiration and ATP production under pressure overload.","evidence":"Cardiac-specific KO with TAC, mitochondrial respiration on permeabilized fibers, and ATP production assays","pmids":["22870288"],"confidence":"High","gaps":["No baseline phenotype, so trigger of HSPB2 dependence unclear","Mitochondrial protein clients not identified"]},{"year":2015,"claim":"Mapped the cardiac HSPB2 interactome and validated GAPDH as a client, supporting non-redundant function relative to HspB5.","evidence":"Cardiac yeast two-hybrid screen, co-IP, and in vitro chaperone assay with GAPDH","pmids":["26465331"],"confidence":"Medium","gaps":["Most interactome hits not individually validated","Functional consequence of GAPDH chaperoning in vivo untested"]},{"year":2017,"claim":"Positioned HSPB2 within the BAG3 co-chaperone network, showing it binds BAG3 weakly and competes with HSPB8, with HSPB3 negatively regulating the interaction.","evidence":"Reciprocal co-IP in overexpression and endogenous human myoblast settings","pmids":["28181153"],"confidence":"Medium","gaps":["Single lab; affinity not quantified","Functional outcome of HSPB2-BAG3 binding in muscle not defined"]},{"year":2023,"claim":"Extended HSPB2 function to the CNS, showing it drives autophagy-dependent neural regeneration after TBI via a BAG3/p62 complex.","evidence":"Neuron-specific transgenic overexpression in a TBI model with autophagy flux assays, co-IP, chloroquine inhibition, and behavioral tests","pmids":["37606039"],"confidence":"Medium","gaps":["Overexpression model; endogenous neuronal role untested","Direct mechanistic link between the complex and autophagosome formation not resolved"]},{"year":null,"claim":"How HSPB2's distinct functional states—the inert HSPB2/B3 complex, the active homomeric chaperone, and the kinase-activating and BAG3-associated forms—are switched and coordinated in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No in vivo identification of the mitochondrial clients underlying cardiac energetic protection","Mechanism toggling HSPB2 between complexed and chaperone-active states unknown","Whether DMPK activation, apoptosis suppression, and autophagy roles share a common molecular basis is undetermined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[9,11]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,8]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,3]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[2,10]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[3]}],"pathway":[],"complexes":["HSPB2/HSPB3 hetero-oligomer (3:1)","HSPB2/BAG3/p62 complex"],"partners":["HSPB3","DMPK","BAG3","SQSTM1","GAPDH","HSPB8"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q16082","full_name":"Heat shock protein beta-2","aliases":["DMPK-binding protein","MKBP","Heat shock protein family B member 2"],"length_aa":182,"mass_kda":20.2,"function":"May regulate the kinase DMPK","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q16082/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HSPB2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HSPB2","total_profiled":1310},"omim":[{"mim_id":"604794","title":"TASTE RECEPTOR, TYPE 2, MEMBER 8; TAS2R8","url":"https://www.omim.org/entry/604794"},{"mim_id":"602179","title":"HEAT-SHOCK 27-KD PROTEIN 2; HSPB2","url":"https://www.omim.org/entry/602179"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"heart muscle","ntpm":219.0},{"tissue":"skeletal muscle","ntpm":235.6},{"tissue":"tongue","ntpm":295.9}],"url":"https://www.proteinatlas.org/search/HSPB2"},"hgnc":{"alias_symbol":["Hs.78846","MKBP"],"prev_symbol":[]},"alphafold":{"accession":"Q16082","domains":[{"cath_id":"2.60.40.790","chopping":"13-151","consensus_level":"high","plddt":78.3828,"start":13,"end":151}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16082","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16082-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16082-F1-predicted_aligned_error_v6.png","plddt_mean":74.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HSPB2","jax_strain_url":"https://www.jax.org/strain/search?query=HSPB2"},"sequence":{"accession":"Q16082","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16082.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16082/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16082"}},"corpus_meta":[{"pmid":"10625651","id":"PMC_10625651","title":"Muscle develops a specific form of small heat shock protein complex composed of MKBP/HSPB2 and HSPB3 during myogenic differentiation.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10625651","citation_count":247,"is_preprint":false},{"pmid":"15480735","id":"PMC_15480735","title":"Comparison of the small heat shock proteins alphaB-crystallin, MKBP, HSP25, HSP20, and cvHSP in heart and skeletal muscle.","date":"2004","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15480735","citation_count":135,"is_preprint":false},{"pmid":"9490724","id":"PMC_9490724","title":"MKBP, a novel member of the small heat shock protein family, binds and activates the myotonic dystrophy protein kinase.","date":"1998","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9490724","citation_count":121,"is_preprint":false},{"pmid":"14592939","id":"PMC_14592939","title":"Roles for alphaB-crystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion-induced damage in a KO mouse model.","date":"2003","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14592939","citation_count":98,"is_preprint":false},{"pmid":"14629120","id":"PMC_14629120","title":"Expression of small heat shock proteins HspB2, HspB8, Hsp20 and cvHsp in different tissues of the perinatal developing pig.","date":"2003","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/14629120","citation_count":73,"is_preprint":false},{"pmid":"11697892","id":"PMC_11697892","title":"Association of HSPB2, a member of the small heat shock protein family, with mitochondria.","date":"2001","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/11697892","citation_count":52,"is_preprint":false},{"pmid":"19715703","id":"PMC_19715703","title":"The small heat-shock proteins HSPB2 and HSPB3 form well-defined heterooligomers in a unique 3 to 1 subunit ratio.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19715703","citation_count":45,"is_preprint":false},{"pmid":"16217658","id":"PMC_16217658","title":"Ischemia-induced increase of stiffness of alphaB-crystallin/HSPB2-deficient myocardium.","date":"2005","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16217658","citation_count":41,"is_preprint":false},{"pmid":"17873008","id":"PMC_17873008","title":"CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice.","date":"2007","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17873008","citation_count":38,"is_preprint":false},{"pmid":"29969581","id":"PMC_29969581","title":"Terminal Regions Confer Plasticity to the Tetrameric Assembly of Human HspB2 and HspB3.","date":"2018","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29969581","citation_count":38,"is_preprint":false},{"pmid":"12403771","id":"PMC_12403771","title":"Orientation-dependent influence of an intergenic enhancer on the promoter activity of the divergently transcribed mouse Shsp/alpha B-crystallin and Mkbp/HspB2 genes.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12403771","citation_count":35,"is_preprint":false},{"pmid":"24859470","id":"PMC_24859470","title":"As a novel p53 direct target, bidirectional gene HspB2/αB-crystallin regulates the ROS level and Warburg effect.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24859470","citation_count":34,"is_preprint":false},{"pmid":"17846079","id":"PMC_17846079","title":"Unmasking different mechanical and energetic roles for the small heat shock proteins CryAB and HSPB2 using genetically modified mouse hearts.","date":"2007","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17846079","citation_count":31,"is_preprint":false},{"pmid":"20087649","id":"PMC_20087649","title":"The small heat shock protein HspB2 is a novel anti-apoptotic protein that inhibits apical caspase activation in the extrinsic apoptotic pathway.","date":"2010","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/20087649","citation_count":29,"is_preprint":false},{"pmid":"10355872","id":"PMC_10355872","title":"Transient up-regulation of myotonic dystrophy protein kinase-binding protein, MKBP, and HSP27 in the neonatal myocardium.","date":"1999","source":"Cell structure and function","url":"https://pubmed.ncbi.nlm.nih.gov/10355872","citation_count":28,"is_preprint":false},{"pmid":"22272249","id":"PMC_22272249","title":"HspB2/myotonic dystrophy protein kinase binding protein (MKBP) as a novel molecular chaperone: structural and functional aspects.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22272249","citation_count":26,"is_preprint":false},{"pmid":"35154459","id":"PMC_35154459","title":"miR-17-5p promotes the invasion and migration of colorectal cancer by regulating HSPB2.","date":"2022","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35154459","citation_count":25,"is_preprint":false},{"pmid":"31692031","id":"PMC_31692031","title":"Molecular chaperone HspB2 inhibited pancreatic cancer cell proliferation via activating p53 downstream gene RPRM, BAI1, and TSAP6.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31692031","citation_count":23,"is_preprint":false},{"pmid":"33032360","id":"PMC_33032360","title":"Mog1 knockout causes cardiac hypertrophy and heart failure by downregulating tbx5-cryab-hspb2 signalling in zebrafish.","date":"2020","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33032360","citation_count":20,"is_preprint":false},{"pmid":"31479860","id":"PMC_31479860","title":"Microstructural changes in the brain mediate the association of AK4, IGFBP5, HSPB2, and ITPK1 with cognitive decline.","date":"2019","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/31479860","citation_count":19,"is_preprint":false},{"pmid":"28181153","id":"PMC_28181153","title":"An interaction study in mammalian cells demonstrates weak binding of HSPB2 to BAG3, which is regulated by HSPB3 and abrogated by HSPB8.","date":"2017","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/28181153","citation_count":19,"is_preprint":false},{"pmid":"15693623","id":"PMC_15693623","title":"Sequence and functional conservation of the intergenic region between the head-to-head genes encoding the small heat shock proteins alphaB-crystallin and HspB2 in the mammalian lineage.","date":"2004","source":"Journal of molecular evolution","url":"https://pubmed.ncbi.nlm.nih.gov/15693623","citation_count":17,"is_preprint":false},{"pmid":"22870288","id":"PMC_22870288","title":"HSPB2 is dispensable for the cardiac hypertrophic response but reduces mitochondrial energetics following pressure overload in mice.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22870288","citation_count":17,"is_preprint":false},{"pmid":"18615620","id":"PMC_18615620","title":"HSPB2/MKBP, a novel and unique member of the small heat-shock protein family.","date":"2008","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/18615620","citation_count":13,"is_preprint":false},{"pmid":"37606039","id":"PMC_37606039","title":"HSPB2 facilitates neural regeneration through autophagy for sensorimotor recovery after traumatic brain injury.","date":"2023","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/37606039","citation_count":12,"is_preprint":false},{"pmid":"17939115","id":"PMC_17939115","title":"Regulation of the mouse alphaB-crystallin and MKBP/HspB2 promoter activities by shared and gene specific intergenic elements: the importance of context dependency.","date":"2007","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17939115","citation_count":11,"is_preprint":false},{"pmid":"26465331","id":"PMC_26465331","title":"Characterization of the Cardiac Overexpression of HSPB2 Reveals Mitochondrial and Myogenic Roles Supported by a Cardiac HspB2 Interactome.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26465331","citation_count":10,"is_preprint":false},{"pmid":"34101831","id":"PMC_34101831","title":"αB-crystallin/HSPB2 is critical for hyperactive mTOR-induced cardiomyopathy.","date":"2021","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34101831","citation_count":5,"is_preprint":false},{"pmid":"27330996","id":"PMC_27330996","title":"αB-crystallin and HspB2 deficiency is protective from diet-induced glucose intolerance.","date":"2016","source":"Genomics data","url":"https://pubmed.ncbi.nlm.nih.gov/27330996","citation_count":5,"is_preprint":false},{"pmid":"38183537","id":"PMC_38183537","title":"Rapamycin protects mouse skin from ultraviolet B-induced photodamage by modulating Hspb2-mediated autophagy and apoptosis.","date":"2024","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/38183537","citation_count":3,"is_preprint":false},{"pmid":"38298658","id":"PMC_38298658","title":"G-quadruplex formation within the promoter region of HSPB2 and its effect on transcription.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38298658","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18556,"output_tokens":4083,"usd":0.058457,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11839,"output_tokens":4363,"usd":0.084135,"stage2_stop_reason":"end_turn"},"total_usd":0.142592,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"HSPB2/MKBP physically associates with myotonic dystrophy protein kinase (DMPK), enhances its kinase activity in vitro, and protects it from heat-induced inactivation. HSPB2 exists as an oligomeric complex in muscle cytosol that is separate from the complex formed by alphaB-crystallin and HSP27.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase activity assay, heat-inactivation protection assay, immunohistochemistry\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of kinase activation and heat protection, combined with co-IP binding and cellular localization; foundational study replicated in subsequent work\",\n      \"pmids\": [\"9490724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HSPB2/MKBP and HSPB3 form a muscle-specific oligomeric complex (~150 kDa) that is completely independent of oligomers formed by HSP27, alphaB-crystallin, and p20. Interaction with DMPK was observed only for HSPB2 and not for the other sHSPs tested. HSPB2 did not associate with actin bundles in myotubes (unlike HSP27 and alphaB-crystallin). Expression of HSPB2 and HSPB3 is induced during muscle differentiation under control of MyoD.\",\n      \"method\": \"Native gel electrophoresis, co-immunoprecipitation, immunofluorescence, gel filtration chromatography, Western blot during differentiation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (native PAGE, Co-IP, immunofluorescence) in a single rigorous study; independently consistent with PMID 9490724\",\n      \"pmids\": [\"10625651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"HSPB2 localizes to mitochondria-associated cytoplasmic granules in differentiated muscle cells. Upon mild heat treatment, HSPB2 enriches in the mitochondrial fraction as shown by subcellular fractionation. Overexpression of HSPB2 protects cells from heat-induced cell death. Colocalization with mitochondria is independent of microtubules (not altered by colchicine).\",\n      \"method\": \"Immunofluorescence double-staining with mitochondrial markers, subcellular fractionation, colchicine treatment, cell viability assay\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by fractionation and co-staining with functional (cytoprotection) follow-up, single lab\",\n      \"pmids\": [\"11697892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In ischemic heart and skeletal muscle, HSPB2 translocates from cytosol to the Z-/I-area of myofibrils. HSPB2 binds partially to actin-associated myofibrillar proteins (extractable by 1 M NaSCN, unlike alphaB-crystallin). This translocation is shared with other sHSPs under ischemic stress.\",\n      \"method\": \"Immunohistochemistry, subcellular fractionation with chaotropic extraction (NaSCN, urea), electron microscopy\",\n      \"journal\": \"Histochemistry and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by fractionation and immunohistochemistry with functional context, single lab\",\n      \"pmids\": [\"15480735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Hearts from alphaBC/HSPB2 double-knockout mice show a twofold reduction in contractile recovery after ischemia-reperfusion, increased necrosis and apoptosis, and 43% less reduced glutathione compared to wild-type, demonstrating that alphaBC and/or HSPB2 are required for myocardial protection from I/R injury.\",\n      \"method\": \"Knockout mouse model, isolated perfused heart I/R protocol, echocardiography, electron microscopy, glutathione assay, histology\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined cardiac phenotype and biochemical readout, but effects cannot be attributed exclusively to HSPB2 vs alphaBC since both genes are knocked out\",\n      \"pmids\": [\"14592939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Isolated papillary muscles from alphaB-crystallin/HSPB2 double-knockout mice develop ischemic contracture earlier and to a higher degree during simulated ischemia, with attenuated recovery during reperfusion, indicating that alphaBC and/or HSPB2 maintain muscular elasticity during ischemia rather than supporting contraction itself (twitch force was not significantly altered).\",\n      \"method\": \"Isolated papillary muscle mechanical measurements, simulated ischemia-reperfusion, double-knockout mouse model\",\n      \"journal\": \"Pflugers Archiv : European journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct mechanical measurement in KO model with specific phenotypic readout, but dual KO precludes attribution solely to HSPB2\",\n      \"pmids\": [\"16217658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Using mice with no HSPB2 (DKO crossed with CryAB transgenic), HSPB2 was found to specifically protect cardiac energetic balance: absence of HSPB2 caused impaired ATP and PCr recovery during reperfusion and massive energy wasting during inotropic stimulation, whereas CryAB protected mechanical/structural properties. These roles are non-redundant.\",\n      \"method\": \"31P NMR spectroscopy of isolated hearts, genetically modified mouse lines (DKO, CryAB transgenic, DKO/CryAB transgenic), ischemia/reperfusion and inotropic stress protocols\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — 31P NMR energetics in genetically stratified mouse lines cleanly dissecting HSPB2 from CryAB function with multiple orthogonal readouts\",\n      \"pmids\": [\"17846079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Recombinant HSPB2 and HSPB3 form well-defined hetero-oligomers of 4, 8, 12, 16, 20, and 24 subunits in a strict 3:1 HSPB2:HSPB3 ratio. These complexes are thermally stable up to 40°C. The HSPB2/B3 complex exhibits poor chaperone-like activity (low surface hydrophobicity) and cannot interact with HSP20, HSP27, or alphaB-crystallin. Homomeric HSPB2 (not in complex with HSPB3) can associate with HSP20.\",\n      \"method\": \"Nanoelectrospray ionization mass spectrometry, sedimentation velocity analytical ultracentrifugation, circular dichroism spectroscopy, ANS fluorescence, co-immunoprecipitation\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted complex from recombinant proteins with multiple orthogonal biophysical methods in one rigorous study\",\n      \"pmids\": [\"19715703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HspB2 inhibits apoptosis by suppressing activation of apical caspases-8 and -10 in the extrinsic apoptotic pathway, thereby blocking Bid cleavage and caspase-3 activation. Ectopic expression of HspB2 in breast cancer cells confers resistance to TRAIL- and TNF-α-induced apoptosis, and attenuates TRAIL anti-tumor activity in an orthotopic xenograft model.\",\n      \"method\": \"Ectopic overexpression in breast cancer cell lines, caspase activity assays, Bid cleavage immunoblot, caspase-3 activation assay, orthotopic xenograft mouse model\",\n      \"journal\": \"Breast cancer research and treatment\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional overexpression with defined molecular pathway readouts (caspase-8/10 and Bid cleavage) and in vivo validation, single lab\",\n      \"pmids\": [\"20087649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HspB2 exhibits concentration-dependent oligomerization, subunit exchange between oligomers, and target protein-dependent chaperone activity in vitro: it prevents DTT-induced aggregation of insulin and heat-induced aggregation of alcohol dehydrogenase, partially prevents citrate synthase aggregation (co-precipitating with it), and suppresses amyloid fibril formation of α-synuclein.\",\n      \"method\": \"Sedimentation velocity, FRET subunit exchange assay, in vitro aggregation assays (insulin, ADH, citrate synthase), thioflavin T amyloid assay, far-UV CD, ANS fluorescence\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with multiple substrates and multiple orthogonal biophysical methods, single lab\",\n      \"pmids\": [\"22272249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Cardiac-specific HSPB2 knockout mice show no difference in cardiac function or hypertrophic response at baseline or after pressure overload (transverse aortic constriction), but exhibit significantly reduced fatty acid-supported mitochondrial respiration and ATP production after TAC, indicating HSPB2 specifically supports mitochondrial metabolic function under cardiac stress.\",\n      \"method\": \"Cardiac-specific knockout mouse model, TAC surgery, echocardiography, mitochondrial respiration assay on permeabilized fibers, ATP production assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cardiac-specific KO isolating HSPB2 function from CryAB, multiple functional readouts including direct mitochondrial assays\",\n      \"pmids\": [\"22870288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cardiac yeast two-hybrid screen and co-immunoprecipitation identified an HSPB2 cardiac interactome enriched in myofibril and mitochondrial proteins. GAPDH was validated as a client protein of HSPB2 through chaperone assays. The interactome partially overlaps with but is distinct from that of HspB5, supporting non-redundant functions.\",\n      \"method\": \"Yeast two-hybrid (cardiac library), co-immunoprecipitation, in vitro chaperone assay with GAPDH\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Y2H combined with co-IP validation and chaperone assay for GAPDH, single lab\",\n      \"pmids\": [\"26465331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In mammalian cells, HSPB2 binds to BAG3 with weaker affinity than HSPB8. HSPB2 competes with HSPB8 for BAG3 binding. HSPB3 negatively regulates HSPB2 association with BAG3. In human myoblasts endogenously expressing HSPB2, HSPB3, HSPB8, and BAG3, BAG3 interacts selectively with HSPB8 rather than HSPB2.\",\n      \"method\": \"Co-immunoprecipitation in mammalian cells (overexpression), endogenous co-IP in human myoblasts\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — reciprocal co-IP in both overexpression and endogenous settings, single lab, two conditions tested\",\n      \"pmids\": [\"28181153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of human HspB2/B3 revealed a hetero-tetrameric assembly (3:1 HspB2:HspB3 ratio) where four α-crystallin domains form a flattened tetrahedron. Assembly is mediated by IXI/V motifs from terminal regions filling ACD pockets, and N-terminal region segments bind in unfolded conformation into anti-parallel shared ACD dimer grooves.\",\n      \"method\": \"X-ray crystallography of full-length human HspB2/B3 hetero-tetramer\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure of full-length human heteromer providing atomic-resolution assembly mechanism, consistent with prior biochemical data\",\n      \"pmids\": [\"29969581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HSPB2 promotes neural regeneration and sensorimotor recovery after traumatic brain injury through autophagy. Mechanistically, HSPB2 may regulate autophagy by forming a complex with BAG3 and sequestosome-1/p62 to facilitate clearance of accumulated proteins in axons. Neuron-specific HSPB2 overexpression enhanced white matter integrity and CNS plasticity; autophagy inhibition (chloroquine) abrogated HSPB2's reparative function.\",\n      \"method\": \"Tamoxifen-induced neuron-specific transgenic overexpression mouse model, TBI model, autophagy flux assays, co-immunoprecipitation (HSPB2/BAG3/p62 complex), chloroquine inhibition, behavioral sensorimotor tests\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic overexpression with co-IP evidence for complex formation and pharmacological validation via autophagy inhibition, single lab\",\n      \"pmids\": [\"37606039\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HSPB2 (MKBP) is a muscle-enriched small heat shock protein that forms a hetero-oligomeric complex with HSPB3 in a 3:1 ratio (crystal structure resolved), binds and activates myotonic dystrophy protein kinase (DMPK), exhibits target-dependent chaperone activity, localizes to mitochondria-associated compartments under stress, protects cardiac energetic balance (ATP/PCr) during ischemia-reperfusion and pressure overload by supporting mitochondrial function, inhibits extrinsic apoptosis by blocking caspase-8/10 activation, and promotes autophagy-dependent neural regeneration via a BAG3/p62 complex.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HSPB2 (MKBP) is a muscle-enriched small heat shock protein whose expression is induced during myogenic differentiation under MyoD control and that functions in cytoprotection, mitochondrial metabolic support, and protein quality control [#1]. It assembles into a hetero-oligomeric complex with HSPB3 in a strict 3:1 stoichiometry; the resolved crystal structure shows four α-crystallin domains forming a flattened tetrahedron stabilized by IXI/V motifs filling ACD pockets and N-terminal segments threading into shared ACD dimer grooves [#7, #13]. This complex is distinct and independent from the oligomers formed by HSP27, αB-crystallin, and HSP20, underscoring a non-redundant role for HSPB2 in muscle [#1, #7]. HSPB2 binds and selectively activates myotonic dystrophy protein kinase (DMPK), enhancing its activity and protecting it from heat inactivation [#0]. Beyond DMPK, HSPB2 displays target-dependent chaperone activity, suppressing aggregation of diverse substrates including insulin, alcohol dehydrogenase, citrate synthase, α-synuclein amyloid, and the validated cardiac client GAPDH [#9, #11]. In muscle it localizes to mitochondria-associated granules and translocates to myofibrillar Z-/I-bands or the mitochondrial fraction under heat or ischemic stress [#2, #3]. Cardiac-specific and double-knockout mouse studies establish that HSPB2 specifically preserves cardiac energetic balance—supporting ATP/phosphocreatine recovery and fatty-acid-supported mitochondrial respiration during ischemia-reperfusion and pressure overload—a function non-redundant with αB-crystallin's protection of mechanical/structural properties [#6, #10]. HSPB2 also inhibits extrinsic apoptosis by suppressing caspase-8/10 activation and downstream Bid cleavage [#8], and promotes autophagy-dependent neural regeneration after traumatic brain injury via a complex with BAG3 and p62/sequestosome-1 [#14]. Its interactions with BAG3 are weaker than those of HSPB8 and are negatively regulated by HSPB3 [#12].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established the founding molecular function of HSPB2 by showing it is a kinase-binding chaperone that physically associates with and activates DMPK, distinguishing it from other muscle sHSPs.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro kinase activation, and heat-inactivation protection assays in muscle\",\n      \"pmids\": [\"9490724\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of DMPK binding not defined\", \"Physiological consequence of DMPK activation in vivo not tested\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined HSPB2's partner specificity by showing it forms a dedicated muscle-specific HSPB2/HSPB3 oligomer independent of other sHSPs, induced during MyoD-driven differentiation.\",\n      \"evidence\": \"Native PAGE, co-IP, gel filtration, and immunofluorescence in differentiating muscle cells\",\n      \"pmids\": [\"10625651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry not yet quantified\", \"Functional consequence of HSPB3 partnership unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Linked HSPB2 to organelle protection by demonstrating mitochondria-associated localization and stress-induced mitochondrial enrichment with cytoprotective effect.\",\n      \"evidence\": \"Immunofluorescence co-staining, subcellular fractionation, colchicine treatment, and viability assays in muscle cells\",\n      \"pmids\": [\"11697892\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mitochondrial recruitment mechanism unknown\", \"Single lab; molecular target at mitochondria not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed stress-dependent relocalization of HSPB2 to myofibrillar Z-/I-bands during ischemia, indicating a context-specific cytoskeletal protective role.\",\n      \"evidence\": \"Immunohistochemistry, chaotropic extraction fractionation, and electron microscopy in ischemic muscle\",\n      \"pmids\": [\"15480735\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific myofibrillar binding partners not identified\", \"Translocation shared with other sHSPs, limiting specificity\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Provided genetic evidence that αBC and/or HSPB2 are required for myocardial protection from ischemia-reperfusion injury.\",\n      \"evidence\": \"αBC/HSPB2 double-knockout mouse hearts in isolated perfused I/R protocol with glutathione and histology readouts\",\n      \"pmids\": [\"14592939\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Dual KO cannot attribute effect to HSPB2 alone\", \"Mechanism connecting HSPB2 to glutathione status unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Refined the cardiac phenotype to maintenance of muscular elasticity during ischemia rather than active contraction.\",\n      \"evidence\": \"Isolated papillary muscle mechanics under simulated I/R in double-knockout mice\",\n      \"pmids\": [\"16217658\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Dual KO precludes HSPB2-specific attribution\", \"Molecular basis of elasticity maintenance not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genetically dissected HSPB2 from αB-crystallin, assigning HSPB2 a specific, non-redundant role in preserving cardiac energetic balance.\",\n      \"evidence\": \"31P NMR energetics in genetically stratified mouse lines (DKO, CryAB transgenic) under I/R and inotropic stress\",\n      \"pmids\": [\"17846079\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between HSPB2 and ATP/PCr metabolism not pinpointed\", \"Mitochondrial client mediating energetics not yet identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established the precise assembly and biophysical properties of the HSPB2/B3 complex, including its strict 3:1 stoichiometry and poor general chaperone activity.\",\n      \"evidence\": \"Native mass spectrometry, analytical ultracentrifugation, CD, ANS fluorescence, and co-IP on recombinant proteins\",\n      \"pmids\": [\"19715703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure not yet resolved\", \"Reconciliation of poor chaperone activity with cytoprotective role unaddressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified an anti-apoptotic function of HSPB2 acting on the extrinsic pathway by suppressing apical caspase-8/10 activation.\",\n      \"evidence\": \"Ectopic overexpression in breast cancer cells with caspase and Bid cleavage assays and orthotopic xenograft model\",\n      \"pmids\": [\"20087649\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular target in the caspase cascade not identified\", \"Overexpression context; endogenous relevance in muscle untested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrated that monomeric/homomeric HSPB2 has target-dependent chaperone activity against multiple aggregation-prone substrates, distinguishing its solo behavior from the inert HSPB2/B3 complex.\",\n      \"evidence\": \"Sedimentation velocity, FRET subunit exchange, and in vitro aggregation/amyloid assays with insulin, ADH, citrate synthase, and α-synuclein\",\n      \"pmids\": [\"22272249\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological substrates in vivo not established\", \"Determinants of target selectivity unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Used cardiac-specific knockout to isolate HSPB2 function, showing it specifically supports mitochondrial respiration and ATP production under pressure overload.\",\n      \"evidence\": \"Cardiac-specific KO with TAC, mitochondrial respiration on permeabilized fibers, and ATP production assays\",\n      \"pmids\": [\"22870288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No baseline phenotype, so trigger of HSPB2 dependence unclear\", \"Mitochondrial protein clients not identified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Mapped the cardiac HSPB2 interactome and validated GAPDH as a client, supporting non-redundant function relative to HspB5.\",\n      \"evidence\": \"Cardiac yeast two-hybrid screen, co-IP, and in vitro chaperone assay with GAPDH\",\n      \"pmids\": [\"26465331\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Most interactome hits not individually validated\", \"Functional consequence of GAPDH chaperoning in vivo untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Positioned HSPB2 within the BAG3 co-chaperone network, showing it binds BAG3 weakly and competes with HSPB8, with HSPB3 negatively regulating the interaction.\",\n      \"evidence\": \"Reciprocal co-IP in overexpression and endogenous human myoblast settings\",\n      \"pmids\": [\"28181153\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; affinity not quantified\", \"Functional outcome of HSPB2-BAG3 binding in muscle not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended HSPB2 function to the CNS, showing it drives autophagy-dependent neural regeneration after TBI via a BAG3/p62 complex.\",\n      \"evidence\": \"Neuron-specific transgenic overexpression in a TBI model with autophagy flux assays, co-IP, chloroquine inhibition, and behavioral tests\",\n      \"pmids\": [\"37606039\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Overexpression model; endogenous neuronal role untested\", \"Direct mechanistic link between the complex and autophagosome formation not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How HSPB2's distinct functional states—the inert HSPB2/B3 complex, the active homomeric chaperone, and the kinase-activating and BAG3-associated forms—are switched and coordinated in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo identification of the mitochondrial clients underlying cardiac energetic protection\", \"Mechanism toggling HSPB2 between complexed and chaperone-active states unknown\", \"Whether DMPK activation, apoptosis suppression, and autophagy roles share a common molecular basis is undetermined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [9, 11]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2, 10]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": []}\n    ],\n    \"complexes\": [\n      \"HSPB2/HSPB3 hetero-oligomer (3:1)\",\n      \"HSPB2/BAG3/p62 complex\"\n    ],\n    \"partners\": [\n      \"HSPB3\",\n      \"DMPK\",\n      \"BAG3\",\n      \"SQSTM1\",\n      \"GAPDH\",\n      \"HSPB8\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":8,"faith_total":9,"faith_pct":88.88888888888889}}